Kite Pharma · 2 weeks ago
Senior Manager, Global Commercial Strategy - Multiple Myeloma
San Francisco Bay Area
Full-time
Hybrid
Senior Level
$154K/yr - $199K/yr
6+ years expKite Pharma is a biopharmaceutical company focused on developing innovative cancer immunotherapies. They are seeking a results-driven Senior Manager for Global Commercial Strategy in Multiple Myeloma to lead cross-functional teams in preparing for the worldwide launch of their therapies and to drive global brand strategy and stakeholder engagement.
BiotechnologyHealth CareMedicalOncologyTherapeutics
Responsibilities
Lead coordination, facilitation, process management for cross-functional global strategic deliverables (Global Strategic Plan, Plan of Action/Launch Priorities), global launch readiness (Launch Readiness Reviews)
Lead strategic planning, objectives, and support logistics for global Advisory Boards with key external audiences
Co-lead and oversee team operations, including global commercial decision-making forums (Global Brand Team with Kite and Arcellx cross-functional leads)
Support launch readiness, execution excellence, and best practice sharing in close partnership with Regional and Local teams
Support strategic planning for global congresses and OL engagement
Synthesize market landscape and competitive insights to inform commercial perspective for differentiated brand strategy and lifecycle management
Support optimal resource allocation, by tracking priorities, budget, contract submissions
Support ad hoc workstreams that arise within global commercial and program team
Anticipated international and domestic travel up to 20%
Deliver global launch readiness and execution excellence for Multiple Myeloma, achieving commercialization and patient objectives
Partner for global commercial strategy and assessments to guide program strategy
Expand access for CAR T globally and establish best-in-class therapies in competitive environments
Qualification
Required
PhD /PharmD and 2 years of experience
OR
Master's degree and 6 years of experience
OR
Bachelor's degree and 8 years of experience
OR
Associate degree and 10 years of experience
OR
High School Diploma / GED degree and 12 years of experience
Preferred
Pharmaceutical global strategic marketing experience, with strong grasp of marketing strategy, market research, segmentation, brand positioning, tactical plan development
Global product launch experience, preferably in hematology and/or cell therapy
Demonstrated ability to partner with regional and local teams to ensure alignment to global strategy while accounting for regional nuances for successful execution
Experience delivering results in co-commercialization partnerships
Strong collaboration skills with cross-functional partners (clinical, medical, tech-ops, regulatory, etc.) to efficiently manage multiple priorities, gain alignment, and drive business objectives
Strong strategic agility and verbal/written communication skills to distill complexity and effectively engage across all levels of the organization
Innovative and resilient in navigating ambiguity and matrixed organizations
Curious, with learning agility and a drive for excellence and high-quality deliverables
Organized with a systematic approach to prioritization, tracking progress, delivering results
Role model of Kite/Gilead core values, inspiring a high-performance culture and engagement
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Kite Pharma
Kite Pharma is a biotechnology company that designs and develops immune-based therapies to treat cancer indications.
1001-5000 employees
H1B Sponsorship
Kite Pharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (47)
2023 (54)
2022 (59)
2021 (53)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$335.38MKey Investors
Alta Partners
2017-08-28Acquired
2015-12-10Post Ipo Equity· $250.12M
2014-06-20IPO
Leadership Team
Craig Vermeyen
Director, Packaging and Labeling
Mark Jurgens
Executive Director, Head of External Scientific Collaboration
Recent News
BioWorld Financial Watch
2025-12-29
2025-12-07
Company data provided by crunchbase